Mangoceuticals (MGRX) vs Park Dental Partners (PARK)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Park Dental Partners is the larger company by market cap ($97.9 million vs $9.4 million), about 10.4 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | MGRX | PARK |
|---|---|---|
| Share price | $0.4351 | $20.58 |
| Market cap | $9.38M | $97.86M |
| 1-day change | -1.91% | -1.72% |
| YTD return | — | +41.87% |
| Forward P/E | — | 13.02 |
| EPS (TTM) | $-1.02 | $-0.89 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $2.75 | $26.79 |
| 52-week low | $0.162 | $9.53 |
| Distance from 52-week high | -84.18% | -23.18% |
| Average volume | 12.83M | 28.42K |
| Shares outstanding | 21.57M | 4.76M |
| Sector | Health Care | Health Care |
| Industry | Misc Health and Biotechnology Services | Misc Health and Biotechnology Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Park Dental Partners is about 10.4 times larger than Mangoceuticals by market value ($97.86M vs $9.38M).
MGRX vs PARK FAQ
Which is bigger, Mangoceuticals or Park Dental Partners?
Park Dental Partners (PARK) is larger, with a market capitalization of $97.86M compared with $9.38M for Mangoceuticals (MGRX).
Are Mangoceuticals and Park Dental Partners in the same industry?
Yes. Both are classified in the Misc Health and Biotechnology Services industry within the Health Care sector.